On Tuesday, June 28, 2022, FDA announced the availability of the proposed rule Nonprescription Drug Product with an Additional Condition for Nonprescription Use (Docket No. FDA-2021-N-0862). The proposed rule outlines requirements for a nonprescription drug product that has an additional condition for nonprescription use (ACNU). The proposed rule intends to increase options for developing and marketing safe […]